World's Best Scientists 2026 revealed!
Tibor Diamantstein

Tibor Diamantstein

D-Index & Metrics

Immunology

D-Index
50
Citations
7120
World Ranking
4282
National Ranking
285

Overview

Tibor Diamantstein was affiliated with Freie Universität Berlin in Germany during their academic career. The scientist's work and contributions to the research community are recorded primarily through their association with this institution.

There is no available record of recent papers, co-authors, publication venues, or book publications attributed to Tibor Diamantstein. Similarly, detailed information on their main fields of study, subfields, or specific research topics is not present in the accessible data.

Likewise, no awards or honors have been documented in connection with their academic profile. While the absence of detailed bibliometric or topical information limits a thorough review of their scientific focus, it reflects a lack of publicly available data rather than the scope of their career.

Due to the lack of specific research outputs, collaborative networks, or publication data in this profile, only their institutional affiliation and the confirmation of their passing can be reported.

Best Publications

  • Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer.

    Thomas Blankenstein;Zheng Hong Qin;K Uberla;Werner Muller

  • Interleukin 7 induces CD4+ T cell-dependent tumor rejection.

    H Hock;M Dorsch;T Diamantstein;T Blankenstein

  • Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma

    Hanno Hock;Marion Dorsch;Ulrich Kunzendorf;Zhihai Qin

  • Interleukin 10 Transfected into Chinese Hamster Ovary Cells Prevents Tumor Growth and Macrophage Infiltration

    Günther Richter;Sabine Krüger-Krasagakes;Gabriela Hein;Christoph Hüls

  • Ki-1 (CD30) antigen is released by Ki-1-positive tumor cells in vitro and in vivo. I. Partial characterization of soluble Ki-1 antigen and detection of the antigen in cell culture supernatants and in serum by an enzyme-linked immunosorbent assay.

    Olivera Josimovic-Alasevic;Horst Dürkop;Roland Schwarting;Eva Backé

  • Expression of interleukin 10 in human melanoma.

    S Krüger-Krasagakes;K Krasagakis;C Garbe;E Schmitt

  • B cell-stimulatory factor 1 (BSF-1) promotes growth of helper T cell lines.

    Rafael Fernandez-Botran;Peter H. Krammer;T. Diamantstein;Jonathan W. Uhr

  • Analysis of cytokine mRNA levels in interleukin-4-transgenic mice by quantitative polymerase chain reaction

    Cornelia Platzer;Günther Richter;Klaus Überla;Werner Müller

  • Therapy with monoclonal antibody to interleukin 2 receptor spares suppressor T cells and prevents or reverses acute allograft rejection in rats.

    Jerzy W. Kupiec-Weglinski;Tibor Diamantstein;Nicholas L. Tilney;Terry B. Strom

  • Vaccinations with Tumor Cells Genetically Engineered to Produce Different Cytokines: Effectivity not Superior to a Classical Adjuvant

    Hanno Hock;Marion Dorsch;Ulrich Kunzendorf;Klaus Überla

  • Lymphotoxin, tumour necrosis factor and interleukin-6 gene transcripts are present in Hodgkin and Reed-Sternberg cells of most Hodgkin's disease cases

    Hans-Dieter Foss;Hermann Herbst;Elisabeth Oelmann;Jens Samol

  • Retroviral expression of the human IL-2 gene in a murine T cell line results in cell growth autonomy and tumorigenicity.

    G Yamada;Y Kitamura;H Sonoda;H Harada

  • Interleukin 2 receptor-targeted therapy--rationale and applications in organ transplantation.

    Jerzy W. Kupiec-Weglinski;Tibor Diamantstein;Nicholas L. Tilney

  • Nucleotide sequence of mouse IL-2 receptor cDNA and its comparison with the human IL-2 receptor sequence

    Akira Shimuzu;Shigeru Kondo;Shun Ichi Takeda;Junji Yodoi

  • The interleukin-2 receptor, its physiology and a new approach to a selective immunosuppressive therapy by anti-interleukin-2 receptor monoclonal antibodies.

    Tibor Diamantstein;Hisao Osawa

  • Generation of competitor DNA fragments for quantitative PCR.

    K Uberla;C Platzer;T Diamantstein;T Blankenstein

  • A rat monoclonal antibody that binds specifically to mouse T lymphoblasts and inhibits IL 2 receptor functions: a putative anti-IL 2 receptor antibody.

    Unknown

  • Monoclonal antibodies identify three epitope clusters on the mouse p55 subunit of the interleukin 2 receptor: relationship to the interleukin 2-binding site.

    Jean‐Louis ‐L Moreau;Markus Nabholz;Tibor Diamantstein;Thomas Malek

  • Interleukin 2-dependent and interleukin 2-independent pathways of regulation of thymocyte function by interleukin 6

    Junming Le;G. Fredrickson;L. F. L. Reis;T. Diamantstein

  • The characteristics of a monoclonal antibody that binds specifically to rat T lymphoblasts and inhibits IL 2 receptor functions.

    Unknown

  • TCGF(IL 2)-receptor inducing factor(s). II. Possible role of ATL-derived factor (ADF) on constitutive IL 2 receptor expression of HTLV-I(+) T cell lines.

    M Okada;M Maeda;Y Tagaya;Y Taniguchi

  • Serum levels of soluble CD30 molecule (Ki-1 antigen) in Hodgkin's disease: relationship with disease activity and clinical stage.

    G. Pizzolo;F. Vinante;M. Chilosi;F. Dallenbach

  • Stimulation of DNA synthesis in mouse lymphoid cells by polyanions in vitro. I. Target cells and possible mode of action.

    T. Diamantstein;W. Vogt;H. Rühl;Gudrun Bochert

  • Monoclonal antibody-recognizing cone visual pigment

    Unknown

  • Expression of tumor necrosis factor by different tumor cell lines results either in tumor suppression or augmented metastasis

    Z Qin;S Krüger-Krasagakes;U Kunzendorf;H Hock

Frequent Co-Authors

Thomas Blankenstein
Thomas Blankenstein Max Delbrück Center for Molecular Medicine
Nicholas L. Tilney
Nicholas L. Tilney Brigham and Women's Hospital
Jerzy W. Kupiec-Weglinski
Jerzy W. Kupiec-Weglinski University of California, Los Angeles
Zhihai Qin
Zhihai Qin Chinese Academy of Sciences
Jörg Reimann
Jörg Reimann University of Ulm
Stefan H. E. Kaufmann
Stefan H. E. Kaufmann Max Planck Institute for Infection Biology
Toshimitsu Uede
Toshimitsu Uede Hokkaido University
Hans-Dieter Volk
Hans-Dieter Volk Charité - University Medicine Berlin
Silvia Bulfone-Paus
Silvia Bulfone-Paus University of Manchester
Junji Yodoi
Junji Yodoi Kyoto University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring complementary healthcare degrees can broaden career opportunities. Many students pivot towards nursing programs that integrate immunological principles and patient care.

Accelerated nursing options, such as accelerated fnp programs, offer fast-tracked routes to advanced nursing roles. These programs emphasize clinical immunology, disease prevention, and treatment, making them a practical extension for immunology graduates.

For individuals without a nursing background, online absn programs for non nurses provide flexible learning paths to become registered nurses. These programs often highlight immunological coursework relevant to patient care and research.

Understanding the accessibility of programs is also important. Identifying accelerated nursing programs can help prospective students find feasible options that align with their academic background and career goals.

Similarly, those aiming for practical roles may consider the best easiest lpn programs to get into, offering entry-level nursing credentials that often incorporate immunology fundamentals applicable in clinical settings.

Exploring these related degrees can enrich understanding and open diverse career pathways in healthcare and research fields connected to immunology.

Best Scientists Citing Tibor Diamantstein